|
ZNF654 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.08584318892736E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.9072969566264E-11 |
| Normal-vs-Stage2 |
2.05259997887453E-09 |
| Normal-vs-Stage3 |
1.01030295240889E-14 |
| Normal-vs-Stage4 |
2.16493489801906E-14 |
| Stage1-vs-Stage2 |
8.650600E-01 |
| Stage1-vs-Stage3 |
1.174850E-01 |
| Stage1-vs-Stage4 |
2.795500E-03 |
| Stage2-vs-Stage3 |
3.598400E-01 |
| Stage2-vs-Stage4 |
1.627580E-02 |
| Stage3-vs-Stage4 |
9.962200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.50490772358125E-12 |
| Normal-vs-AfricanAmerican |
3.63370000000529E-05 |
| Normal-vs-Asian |
1.68249969512146E-10 |
| Caucasian-vs-AfricanAmerican |
3.118000E-01 |
| Caucasian-vs-Asian |
9.522200E-01 |
| AfricanAmerican-vs-Asian |
3.412200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78560516267612E-11 |
| Normal-vs-Female |
7.03770375309887E-12 |
| Male-vs-Female |
7.689600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70474745431193E-12 |
| Normal-vs-Age(41-60Yrs) |
6.24733598186822E-12 |
| Normal-vs-Age(61-80Yrs) |
3.89444032578012E-12 |
| Normal-vs-Age(81-100Yrs) |
6.821900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.889960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.280380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.408200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.607800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.376000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.658200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.536300E-02 |
| Classical-VS-Follicular |
3.725800E-01 |
| Classical-VS-Other |
7.270600E-01 |
| Classical-VS-Normal |
5.01449992640346E-10 |
| Tall-VS-Follicular |
1.293970E-01 |
| Tall-VS-Other |
4.254000E-01 |
| Tall-VS-Normal |
1.27410304529008E-11 |
| Follicular-VS-Other |
9.677600E-01 |
| Follicular-VS-Normal |
1.63079549864165E-11 |
| Other-VS-Normal |
3.480300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.55324666859269E-12 |
| Normal-vs-N1 |
5.02764496701502E-12 |
| N0-vs-N1 |
2.801800E-01 |
|
|
